[Initial trials give hope. Anticoagulants against cancer?].
Hiller
Erhard
E
D000925:Anticoagulants / Q000627:therapeutic use*; D018849:Controlled Clinical Trials as Topic; D017985:Dalteparin / Q000627:therapeutic use; D005343:Fibrinolytic Agents / Q000627:therapeutic use; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D009369:Neoplasms / Q000097:blood / Q000150:complications / Q000188:drug therapy* / Q000401:mortality*; D010919:Placebos; D011446:Prospective Studies; D012189:Retrospective Studies; D012307:Risk Factors; D013927:Thrombosis / Q000150:complications / Q000517:prevention & control*; D013997:Time Factors; D014859:Warfarin / Q000627:therapeutic use
D000925:Anticoagulants; D005343:Fibrinolytic Agents; D010919:Placebos; D014859:Warfarin; D006493:Heparin; D017985:Dalteparin